Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 61684 [2016-21399]
Download as PDF
61684
Federal Register / Vol. 81, No. 173 / Wednesday, September 7, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Time and Date: 8:30 a.m.–2:30 p.m.,
EDT, September 27, 2016.
Place: Patriots Plaza I, 395 E Street
SW., Room 9000, Washington, DC
20201. The meeting is also available via
webcast.
Status: This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates approximately 33
people. The public is welcome to
participate during the public comment
period, 12:30 p.m.–12:45 p.m. EDT,
September 27, 2016.
Please note that the public comment
period ends at the time indicated above
or following the last call for comments,
whichever is earlier. Members of the
public who want to comment must sign
up by providing their name by mail,
email, or telephone, at the addresses
provided below by September 23, 2016.
Each commenter will be provided up to
five minutes for comment. A limited
number of time slots are available and
will be assigned on a first come-first
served basis. Written comments will
also be accepted from those unable to
attend the public session via an on-line
form at the following Web site: https://
www.cdc.gov/niosh/bsc/contact.html.
The meeting is also open to the public
via webcast. If you wish to attend in
person or by webcast, please see the
NIOSH Web site to register (https://
www.cdc.gov/niosh/bsc/) or call (404–
498–2539) at least five business days in
advance of the meeting. Teleconference
is available toll-free; please dial (888)
397–9578, Participant Pass Code
63257516. Adobe Connect webcast will
be available at https://
odniosh.adobeconnect.com/nioshbsc/
for participants wanting to connect
remotely.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly
or by grants or contracts, research,
experiments, and demonstrations
VerDate Sep<11>2014
18:44 Sep 06, 2016
Jkt 238001
relating to occupational safety and
health and to mine health. The Board of
Scientific Counselors provides guidance
to the Director, National Institute for
Occupational Safety and Health on
research and prevention programs.
Specifically, the Board provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and
disseminating results. The Board
evaluates the degree to which the
activities of the National Institute for
Occupational Safety and Health: (1)
conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters for Discussion: NIOSH
Director’s update; Chronic Kidney
Disease and Pesticide Exposure; NIOSH
Oil and Gas Sector Program;
Engineering Controls for Additive (3D)
Manufacturing, and Engineering
Controls and Nanomaterials.
Agenda items are subject to change as
priorities dictate.
An agenda is also posted on the
NIOSH Web site (https://www.cdc.gov/
niosh/bsc/). Members of the public who
wish to address the NIOSH BSC are
requested to contact the Executive
Secretary for scheduling purposes (see
contact information below).
Alternatively, written comments to the
BSC may be submitted via an on-line
form at the following Web site: https://
www.cdc.gov/niosh/bsc/contact.html.
Contact Person for More Information:
Paul J. Middendorf, Ph.D., Executive
Secretary, BSC, NIOSH, CDC, 1600
Clifton Road NE., MS–E20, Atlanta, GA
30329–4018, telephone (404) 498–2500,
fax (404) 498–2526.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker, MPH, DLP,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–21399 Filed 9–6–16; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:00 p.m.,
EDT, September 27, 2016; 8:00 a.m.–
12:00 p.m., EDT, September 28, 2016.
Place: CDC, Global Communications
Center, 1600 Clifton Road NE., Building
19, Auditorium B3, Atlanta, Georgia
30333.
Status: The meeting is open to the
public, limited only by the space
available.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: The meeting
will include updates from CDC’s
infectious disease national centers; a
report from the Board’s Food Safety
Modernization Act Surveillance
Working Group; and focused
discussions on several program
priorities, including viral hepatitis,
Zika, and antimicrobial resistance.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
E:\FR\FM\07SEN1.SGM
07SEN1
Agencies
[Federal Register Volume 81, Number 173 (Wednesday, September 7, 2016)]
[Notices]
[Page 61684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21399]
[[Page 61684]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Time and Date: 8:30 a.m.-2:30 p.m., EDT, September 27, 2016.
Place: Patriots Plaza I, 395 E Street SW., Room 9000, Washington,
DC 20201. The meeting is also available via webcast.
Status: This meeting is open to the public, limited only by the
space available. The meeting room accommodates approximately 33 people.
The public is welcome to participate during the public comment period,
12:30 p.m.-12:45 p.m. EDT, September 27, 2016.
Please note that the public comment period ends at the time
indicated above or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name by mail, email, or telephone, at the addresses
provided below by September 23, 2016. Each commenter will be provided
up to five minutes for comment. A limited number of time slots are
available and will be assigned on a first come-first served basis.
Written comments will also be accepted from those unable to attend the
public session via an on-line form at the following Web site: https://www.cdc.gov/niosh/bsc/contact.html. The meeting is also open to the
public via webcast. If you wish to attend in person or by webcast,
please see the NIOSH Web site to register (https://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five business days in advance of
the meeting. Teleconference is available toll-free; please dial (888)
397-9578, Participant Pass Code 63257516. Adobe Connect webcast will be
available at https://odniosh.adobeconnect.com/nioshbsc/ for
participants wanting to connect remotely.
Purpose: The Secretary, the Assistant Secretary for Health, and by
delegation the Director, Centers for Disease Control and Prevention,
are authorized under Sections 301 and 308 of the Public Health Service
Act to conduct directly or by grants or contracts, research,
experiments, and demonstrations relating to occupational safety and
health and to mine health. The Board of Scientific Counselors provides
guidance to the Director, National Institute for Occupational Safety
and Health on research and prevention programs. Specifically, the Board
provides guidance on the Institute's research activities related to
developing and evaluating hypotheses, systematically documenting
findings and disseminating results. The Board evaluates the degree to
which the activities of the National Institute for Occupational Safety
and Health: (1) conform to appropriate scientific standards, (2)
address current, relevant needs, and (3) produce intended results.
Matters for Discussion: NIOSH Director's update; Chronic Kidney
Disease and Pesticide Exposure; NIOSH Oil and Gas Sector Program;
Engineering Controls for Additive (3D) Manufacturing, and Engineering
Controls and Nanomaterials.
Agenda items are subject to change as priorities dictate.
An agenda is also posted on the NIOSH Web site (https://www.cdc.gov/niosh/bsc/). Members of the public who wish to address the NIOSH BSC
are requested to contact the Executive Secretary for scheduling
purposes (see contact information below). Alternatively, written
comments to the BSC may be submitted via an on-line form at the
following Web site: https://www.cdc.gov/niosh/bsc/contact.html.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS-E20,
Atlanta, GA 30329-4018, telephone (404) 498-2500, fax (404) 498-2526.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker, MPH, DLP,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2016-21399 Filed 9-6-16; 8:45 am]
BILLING CODE 4163-19-P